Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The VJSessions have brought together leading experts virtually to help continue the valuable international collaborations in diseases such as Multiple Myeloma, CLL, AML, Lymphoma, MDS and MPNs. You can view our collection of webinar sessions below at your convenience, as well as being able to listen to podcasts of each session on the go.

Multiple Myeloma

Multiple Myeloma

09 Jun 2023

Key highlights from EHA 2023

Jesús San Miguel, Enrique Ocio
17 Mar 2023

iwMyeloma 2023

Leif Bergsagel, Francesco Maura, Jill Corre, Niels Weinhold, Irene Ghobrial, Charlotte Pawlyn, Lawrence Boise, Paola Neri, Maria-Victoria Mateos, Marta Chesi, José Ángel Martínez-Climent, Bruno Paiva, Keith Stewart, Brian Walker, Martin Kortüm, Claudia Stege, Elena Zamagni, Enrique Ocio, Nizar Bahlis, Carlos Fernández De Larrea, Gareth Morgan, Pieter Sonneveld, Sagar Lonial, Yi Lin, Adam Cohen
10 Dec 2022

Key highlights from ASH 2022

Yi Lin, Krina Patel
27 Aug 2022

Updates from IMS 2022

Rakesh Popat, Charlotte Pawlyn, Meral Beksac, Heinz Ludwig, Marta Chesi, Leif Bergsagel, Sonja Zweegman, Claudia Stege, Ola Landgren, Bruno Paiva
30 Apr 2022

iwCAR-T 2022 day 3 highlights with a focus on myeloma

Krina Patel, Suzanne Trudel, Yi Lin, Frederick Locke
11 Jun 2022

Myeloma updates from EHA 2022

Mohamad Mohty, Saad Usmani
12 May 2022

Myeloma treatment in the UK

Martin Kaiser, Graham Jackson
27 Mar 2022

PIKfyve, RAS, the epigenome & PROTAC therapy

Paola Neri, Lawrence Boise
26 Mar 2022

Novel targets in 2022

Faith Davies, Charlotte Pawlyn, Hearn Jay Cho
26 Mar 2022

Day 2 highlights from Myeloma 2022

Gareth Morgan, Rafael Fonseca, Leif Bergsagel, Keith Stewart
26 Mar 2022

T-Cell engagers

Hermann Einsele, Nina Shah, Thomas Martin
26 Mar 2022

Day 1 highlights from Myeloma 2022

Keith Stewart, Gareth Morgan, Faith Davies
26 Mar 2022

Using single-cell analysis to tackle myeloma

Irene Ghobrial, Yael Cohen, Eileen Boyle, Rodger Tiedemann
26 Mar 2022

Genomics in the age of I-O

Gareth Morgan, Francesco Maura, Leo Rasche
27 Jan 2022

Post-ASH 2021

Graham Jackson, Rakesh Popat
11 Dec 2021

A deep dive into screening for precursor conditions

Irene Ghobrial, Sigurdur Kristinsson
20 Jul 2021

Post-EHA/ASCO 2021

Noopur Raje, Katja Weisel, Nina Shah, Yi Lin
08 Jun 2021

The patient perspective

Mohamad Mohty, , , ,
20 May 2021

Post-COMy 2021

Mohamad Mohty, Thierry Facon, Alessandra Larocca
13 Jan 2021

Post-ASH 2020

Maria-Victoria Mateos, Nina Shah, Thomas Martin
13 Jan 2021

Post-ASH 2020 UK

Karthik Ramasamy, Rakesh Popat
13 Aug 2020

Myeloma & COVID-19

Paul Richardson, Evangelos Terpos, Maria-Victoria Mateos, Ajai Chari
01 Jul 2020

COMy & EHA 2020

Francesca Gay, Saad Usmani, Mohamad Mohty
Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes (MDS)

07 Sep 2023

Updates on the diagnosis, risk stratification and treatment of lower-risk MDS

Sanam Loghavi, Rami Komrokji
05 May 2023

Management of anemia in LR-MDS & overcoming treatment failure in HR-MDS

Valeria Santini, Amer Zeidan
01 Mar 2023

Comparing the ICC and WHO classifications for MDS & their impact on clinical practice

Amer Zeidan, Sanam Loghavi, Somedeb Ball, Rami Komrokji
Lymphoma

Lymphoma

29 Sep 2023

iwNHL 2023

Martin Hutchings, Marion Subklewe, Mazyar Shadman, Krish Patel, Tanya Siddiqi, Nirav Niranjan Shah, David Maloney, Jason Westin, David Miklos, John Gribben, Laurie Sehn, Andrew Davies, Sven De Vos, Ash Alizadeh, Laura Pasqualucci, Ken Young, Stephen Ansell, John Kuruvilla, Marek Trněný, Yucai Wang, Francine Foss, Steven Horwitz, Laurence de Leval, François Lemonnier
08 Jun 2023

Updates in CAR-T & bispecific antibodies from EHA 2023

Gloria Iacoboni, Paolo Strati
10 Dec 2022

Key highlights in T-cell lymphoma from ASH 2022

Kate Cwynarski, Swaminathan Iyer